相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)
J. B. Vermorken et al.
ANNALS OF ONCOLOGY (2014)
Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial
Harpreet Wasan et al.
LANCET ONCOLOGY (2014)
Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck
A. Argiris et al.
ANNALS OF ONCOLOGY (2013)
Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck
J. B. Vermorken et al.
EUROPEAN JOURNAL OF CANCER (2013)
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial
Jan B. Vermorken et al.
LANCET ONCOLOGY (2013)
Systemic treatment and medical management of metastatic squamous cell carcinoma of the head and neck: Review of the literature and proposal for management changes
Frederic Peyrade et al.
ORAL ONCOLOGY (2013)
Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of head and neck
R. Hitt et al.
ANNALS OF ONCOLOGY (2012)
Current Treatment Options for Metastatic Head and Neck Cancer
Katharine A. R. Price et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2012)
Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up
V. Gregoire et al.
ANNALS OF ONCOLOGY (2010)
Induction Chemotherapy and Cetuximab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Results From a Phase II Prospective Trial
Merrill S. Kies et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Induction Docetaxel, Cisplatin, and Cetuximab Followed by Concurrent Radiotherapy, Cisplatin, and Cetuximab and Maintenance Cetuximab in Patients With Locally Advanced Head and Neck Cancer
Athanassios Argiris et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Platinum-based chemotherapy plus cetuximab in head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: An eastern cooperative oncology group study
B Burtness et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): An intergroup trial of the eastern cooperative oncology group
MK Gibson et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Therapeutic synergy of oral taxane BMS-275183 and cetuximab versus human tumor xenografts
WC Rose et al.
CLINICAL CANCER RESEARCH (2004)
Phase II trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck
BS Glisson et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
JH Schiller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
C Gedlicka et al.
ONCOLOGY (2002)
Phase II study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck
L Specht et al.
ANNALS OF ONCOLOGY (2000)
分享论文
